IL263174A - תכשירים המכילים קנאבידיול וחומצה היאלורונית לטיפול במחלות מפרקים דלקתיות - Google Patents

תכשירים המכילים קנאבידיול וחומצה היאלורונית לטיפול במחלות מפרקים דלקתיות

Info

Publication number
IL263174A
IL263174A IL263174A IL26317418A IL263174A IL 263174 A IL263174 A IL 263174A IL 263174 A IL263174 A IL 263174A IL 26317418 A IL26317418 A IL 26317418A IL 263174 A IL263174 A IL 263174A
Authority
IL
Israel
Prior art keywords
treatment
hyaluronic acid
preparations containing
joint diseases
inflammatory joint
Prior art date
Application number
IL263174A
Other languages
English (en)
Inventor
Tamir Gedo
Original Assignee
Tamir Gedo
Bol Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tamir Gedo, Bol Pharma Ltd filed Critical Tamir Gedo
Publication of IL263174A publication Critical patent/IL263174A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL263174A 2016-05-24 2018-11-21 תכשירים המכילים קנאבידיול וחומצה היאלורונית לטיפול במחלות מפרקים דלקתיות IL263174A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662340576P 2016-05-24 2016-05-24
PCT/IL2017/050580 WO2017203529A1 (en) 2016-05-24 2017-05-24 Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases

Publications (1)

Publication Number Publication Date
IL263174A true IL263174A (he) 2018-12-31

Family

ID=60411168

Family Applications (1)

Application Number Title Priority Date Filing Date
IL263174A IL263174A (he) 2016-05-24 2018-11-21 תכשירים המכילים קנאבידיול וחומצה היאלורונית לטיפול במחלות מפרקים דלקתיות

Country Status (4)

Country Link
EP (1) EP3463304A4 (he)
CA (1) CA3025208A1 (he)
IL (1) IL263174A (he)
WO (1) WO2017203529A1 (he)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
EP3817750A4 (en) * 2018-07-02 2022-05-04 Companion Sciences, LLC CANNABIDIOL COMBINATION COMPOSITIONS
WO2020021545A1 (en) * 2018-07-25 2020-01-30 Bol Pharma Ltd. Cannabidiol and glucosamine for treating inflammatory joint diseases
WO2020024056A1 (en) * 2018-08-01 2020-02-06 Lazar Eve Compositions comprising cannabinoids and absorbable material and uses thereof
BR112021006858A2 (pt) * 2018-10-10 2021-07-13 Tilray Inc. métodos e formulações para tratar náusea e vômito induzidos por quimioterapia
CN117695226A (zh) 2018-12-11 2024-03-15 迪斯拉普申实验室公司 用于递送治疗剂的组合物及其使用方法和制备方法
WO2020180969A1 (en) * 2019-03-05 2020-09-10 Colleen Smith Veterinary compositions and methods of use therefor
US12403114B2 (en) 2019-03-12 2025-09-02 Epm (Ip), Inc. Cannabinoid acid ester compositions and uses thereof
US20200352849A1 (en) * 2019-05-07 2020-11-12 Adam M. Rotunda Topical Skin Formulations and Wound Care Products with Integrated CBD Delivery Mechanisms for Skin Rejuvenation, Wound Care and Healing, Pain and Itch Relief, and Scar Prevention and Treatment
IT201900008409A1 (it) * 2019-06-07 2020-12-07 Vivatis Pharma Gmbh Individuazione e selezione di un materiale di partenza vegetale di condroitina solfato e acido ialuronico vegetali, e trasformazione di tale materiale di partenza vegetale per l’ottenimento di ingredienti per utilizzo in alimenti, integratori, dispositivi medici o farmaci
CA3156487A1 (en) * 2019-10-03 2021-04-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. LIPOSOMAL CANNABINOIDS AND ASSOCIATED USES
WO2021091905A1 (en) * 2019-11-08 2021-05-14 Vella Bioscience, Inc. Liposomal formulations for delivery of cannabinoids and methods of making thereof
EP4072590A4 (en) * 2019-12-13 2024-01-03 Folium Labs Inc. COMPLEXES COMPRISING A CARBOHYDRATE POLYMER AND AN ACTIVE INGREDIENT AND THEIR PREPARATION PROCESSES
GB201918846D0 (en) * 2019-12-19 2020-02-05 Gw Res Ltd Oral cannabinoid formulations
EP3861996A1 (en) 2020-02-04 2021-08-11 I+Med S. Coop. Controlled release system of phytocannabinoids formulations soluble in aqueous media, methods and uses thereof
CN112138138B (zh) * 2020-11-19 2023-05-23 乐康珍泰（天津）生物技术有限公司 一种用于治疗痛风的药物组合物及其制备方法
CA3217137A1 (en) 2021-04-29 2022-11-03 Christopher Adair Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
US20240226060A1 (en) * 2021-05-03 2024-07-11 Panag Pharma Inc. Topical liposome polyphenol compositions for treating and preventing various skin disorders and methods of preparation thereof
IT202200002000A1 (it) * 2022-02-04 2023-08-04 Mak Pharma S R L Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US10004684B2 (en) * 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
US20110142914A1 (en) * 2007-12-06 2011-06-16 Cytotech Labs, Llc Inhalable compositions having enhanced bioavailability
TWI382841B (zh) * 2010-10-29 2013-01-21 Univ China Medical 用於抑制發炎之醫藥組合物
US20130184354A1 (en) * 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management
US20150004219A1 (en) * 2012-02-02 2015-01-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Stable liposomes for drug delivery
SI2854769T1 (sl) * 2012-07-05 2023-09-29 Taiwan Liposome Company, Ltd. Postopki za zdravljenje artritisa
WO2015068052A2 (en) * 2013-10-31 2015-05-14 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations

Also Published As

Publication number Publication date
CA3025208A1 (en) 2017-11-30
WO2017203529A1 (en) 2017-11-30
EP3463304A4 (en) 2020-01-08
EP3463304A1 (en) 2019-04-10

Similar Documents

Publication Publication Date Title
IL263174A (he) תכשירים המכילים קנאבידיול וחומצה היאלורונית לטיפול במחלות מפרקים דלקתיות
HUE053309T2 (hu) Új sók és gyógyászati készítmények gyulladásos betegségek kezelésére
PL3717471T3 (pl) Nowe związki i zawierające je kompozycje farmaceutyczne do leczenia chorób
IL269158A (he) תכשירים ושיטות לטיפול במחלות דלקתיות
IL255269A (he) תכשירים של חומצה אובתיקולית ושיטות לשימוש
IL256614A (he) תכשירים של טרנסטירתין (ttr) irna ושיטות לשימוש בהם לטיפול או מניעה של מחלות הקשורות ל-ttr
IL258955A (he) תכשירים ושיטות לטיפול בסרטן
IL262608A (he) טיפול משולב בהפרעות ובמחלות דלקתיות בעיניים
PL3600309T3 (pl) Skojarzenia terapeutyczne do leczenia chorób wątroby
HUE053115T2 (hu) Topikális gyógyszerészeti formulációk gyulladással összefüggõ állapotok kezelésére
DK3889145T3 (da) 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
HUE039864T2 (hu) Gyógyászati készítmények CFTR-közvetítette betegségek kezelésére
IL259861A (he) שיטות ותכשירים לטיפול בהפרעות הקשורות להתקפים
IL284125A (he) תולדות קווינולין לשימוש בטיפול במחלות דלקתיות
PL3169328T3 (pl) Pochodne chinoliny do leczenia chorób zapalnych
IL264070A (he) שיטות ותכשירים לטיפול בהפרעות ומחלות המערבות rdh12
DK3509638T3 (da) Præparater med cannabidiolsyreestere og anvendelser deraf
HUE060496T2 (hu) Terápiás vegyületek és készítmények szociális zavarok és szerhasználati zavarok kezelésére
IL258259A (he) טיפול משלים בעזרת הידרוקסי-ויטמון d ותכשירים שכוללים אותו
IL272601A (he) תכשירים רוקחיים לטיפול במצבים אופתלמיים
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
IL233639B (he) תכשירים ושיטות לטיפול במחלות וליקויי כבד
IL268720A (he) פורמולציות של קנאבינואידים לטיפול בדרמטיטיס ומחלות עור דלקתיות
IL269083A (he) שיטות למניעה ולטיפול במחלות לב